Key Highlights

  • Centene (NYSE:CNC) reports third-quarter results before the open on Tuesday, October 27, 2026, with consensus adjusted earnings of USD 0.10 per share in published estimates.
  • In the second quarter, adjusted earnings were USD 2.51 per share, and the consolidated health benefit ratio improved to 89.6% from 93.0% a year earlier.
  • Full-year adjusted earnings guidance was raised to more than USD 4.80 from more than USD 3.40, including a USD 0.50 per share prior-period benefit that will not recur.
  • Management said it expects near-breakeven third-quarter earnings and a fourth-quarter loss, so the USD 0.10 consensus sits close to the company's own signal.

The Setup and the July Guidance

Centene (NYSE:CNC) is a managed care company that covers Medicaid, Medicare and Affordable Care Act marketplace members, and it reports third-quarter results before the open on Tuesday, October 27, 2026. Consensus adjusted earnings are USD 0.10 per share. In its report of Tuesday, July 28, 2026, the company earned USD 2.51 per share, with premium and service revenue of about USD 44.4 billion and an adjusted selling and administrative expense ratio of 6.9%. It raised 2026 adjusted earnings guidance to more than USD 4.80, from more than USD 3.40. Management guided to near-breakeven earnings in the third quarter and a loss in the fourth, a seasonal pattern similar to 2025.

How the Health Benefit Ratio Drives Earnings

Centene (NYSE:CNC) keeps the premium left after paying medical claims, so the health benefit ratio, which is claims as a share of premiums, is the number that moves earnings. In the second quarter the marketplace ratio fell to 79.2% from 90.6%, helped by a USD 180 million favourable 2025 risk adjustment settlement, a stronger relative risk position and moderating cost trends. The Medicare ratio was 89.5% and the Medicaid ratio 93.9%. Marketplace membership was 3.5 million, with modest second-half attrition expected, while Medicaid membership was 12.1 million and the full-year decline is now expected at 8% to 9%, against 6% before. The debt-to-capital ratio improved to 41.6% from 46.5% at the end of 2025.

Risks and What to Watch

The bull case is a third-quarter result above the near-breakeven signal, a marketplace ratio that stays well below last year, and confirmation that guidance above USD 4.80 holds once the USD 0.50 one-time benefit is removed, which would support the shares. The bear case is higher medical cost trends in Medicaid, faster membership losses than the 8% to 9% decline now planned, risk adjustment settlements that reverse, or commentary that points to a weaker 2027 base. The shares fell after the July beat, according to market data, so a strong quarter may already be priced in. Investors should watch the three segment ratios, enrolment, 2027 marketplace commentary and any guidance change, alongside the Federal Reserve decision on Wednesday, October 28, 2026.

Where Things Stand

The answer is that Centene (NYSE:CNC) needs only a small positive result to meet the USD 0.10 consensus, so the segment ratios, membership and the 2027 outlook are likely to decide the reaction. A guidance raise would support the shares, while rising Medicaid costs would test them. The next catalysts are the report before the open on Tuesday, October 27, 2026 and the Federal Reserve decision on Wednesday, October 28, 2026. Consensus figures are estimates, not guarantees, medical cost trends can shift quickly, and this is not investment advice.